197 related articles for article (PubMed ID: 27678372)
1. The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.
Guo ZL; Richardson DR; Kalinowski DS; Kovacevic Z; Tan-Un KC; Chan GC
J Hematol Oncol; 2016 Sep; 9(1):98. PubMed ID: 27678372
[TBL] [Abstract][Full Text] [Related]
2.
Xu YX; Zeng ML; Yu D; Ren J; Li F; Zheng A; Wang YP; Chen C; Tao ZZ
Oncol Lett; 2018 May; 15(5):7999-8004. PubMed ID: 29740495
[TBL] [Abstract][Full Text] [Related]
3. Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.
Sestak V; Stariat J; Cermanova J; Potuckova E; Chladek J; Roh J; Bures J; Jansova H; Prusa P; Sterba M; Micuda S; Simunek T; Kalinowski DS; Richardson DR; Kovarikova P
Oncotarget; 2015 Dec; 6(40):42411-28. PubMed ID: 26623727
[TBL] [Abstract][Full Text] [Related]
4. The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells.
Dharmasivam M; Azad MG; Afroz R; Richardson V; Jansson PJ; Richardson DR
Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130152. PubMed ID: 35436509
[TBL] [Abstract][Full Text] [Related]
5. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc.
Wijesinghe TP; Dharmasivam M; Dai CC; Richardson DR
Pharmacol Res; 2021 Nov; 173():105889. PubMed ID: 34536548
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
Seebacher NA; Richardson DR; Jansson PJ
Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
[TBL] [Abstract][Full Text] [Related]
7. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
[TBL] [Abstract][Full Text] [Related]
8. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
[TBL] [Abstract][Full Text] [Related]
9. Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer.
Shehadeh-Tout F; Milioli HH; Roslan S; Jansson PJ; Dharmasivam M; Graham D; Anderson R; Wijesinghe T; Azad MG; Richardson DR; Kovacevic Z
Pharmacol Res; 2023 Jul; 193():106806. PubMed ID: 37244387
[TBL] [Abstract][Full Text] [Related]
10. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
[TBL] [Abstract][Full Text] [Related]
11. Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms.
Paukovcekova S; Skoda J; Neradil J; Mikulenkova E; Chlapek P; Sterba J; Richardson DR; Veselska R
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334021
[TBL] [Abstract][Full Text] [Related]
12. Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials.
Reimerová P; Stariat J; Bavlovič Piskáčková H; Jansová H; Roh J; Kalinowski DS; Macháček M; Šimůnek T; Richardson DR; Štěrbová-Kovaříková P
Anal Bioanal Chem; 2019 Apr; 411(11):2383-2394. PubMed ID: 30820631
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
[TBL] [Abstract][Full Text] [Related]
14. Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Stariat J; Kovaříková P; Kučera R; Klimeš J; Kalinowski DS; Richardson DR; Ketola RA
Anal Bioanal Chem; 2013 Feb; 405(5):1651-61. PubMed ID: 23180090
[TBL] [Abstract][Full Text] [Related]
15. The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.
Li P; Zheng X; Shou K; Niu Y; Jian C; Zhao Y; Yi W; Hu X; Yu A
Am J Transl Res; 2016; 8(12):5370-5385. PubMed ID: 28078009
[TBL] [Abstract][Full Text] [Related]
16. Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel "Stealth Zinc(II) Complex".
Dharmasivam M; Kaya B; Wijesinghe T; Gholam Azad M; Gonzálvez MA; Hussaini M; Chekmarev J; Bernhardt PV; Richardson DR
J Med Chem; 2023 Jan; 66(2):1426-1453. PubMed ID: 36649565
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells.
Krchniakova M; Paukovcekova S; Chlapek P; Neradil J; Skoda J; Veselska R
Front Pharmacol; 2022; 13():976955. PubMed ID: 36160437
[TBL] [Abstract][Full Text] [Related]
18. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer.
Kovacevic Z; Chikhani S; Lovejoy DB; Richardson DR
Mol Pharmacol; 2011 Oct; 80(4):598-609. PubMed ID: 21719465
[TBL] [Abstract][Full Text] [Related]
19. Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.
Yu Y; Suryo Rahmanto Y; Richardson DR
Br J Pharmacol; 2012 Jan; 165(1):148-66. PubMed ID: 21658021
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake of the antitumor agent Dp44mT occurs via a carrier/receptor-mediated mechanism.
Merlot AM; Pantarat N; Menezes SV; Sahni S; Richardson DR; Kalinowski DS
Mol Pharmacol; 2013 Dec; 84(6):911-24. PubMed ID: 24085840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
